Aim We report diverse phenotypic consequences of the delQKP-1507-1509 cardiac sodium channel mutation in three generations of a Chinese family. Methods and results Clinical and electrocardiographic (ECG), echocardiographic examination was followed by direct sequencing of SCN5A, KCNQ1, HERG, and LAMIN A/C to screen genomic DNA from blood samples. Of two mutation carriers, the proband was born with conduction disorders including second-degree atrioventricular (AV) block with prolonged QTc interval, additionally showing left anterior fascicular block (LAFB), incomplete right bundle-branch block (IRBBB), and intermittent third-degree AV block at 2 years, and clinical presentations of multiple syncope despite normal electroencephalograms at 8 years. Continuous ECG monitoring following presentation at 13 years revealed prolonged QTc and biphasic T-waves, multiple episodes of ventricular tachycardia, ventricular fibrillation, and torsades de pointes. Transthoracal echocardiography then revealed left ventricular dilatation and reduced systolic function. Another mutation carrier showed features of long QT syndrome type 3 (LQT3), LAFB, and dilated cardiomyopathy (DCM). Two additional subjects died suddenly at 13 and 33 years. Conclusion This data compliments and expands the spectrum of phenotypes resulting from this known gain-of-function mutation, including not only LQT3, cardiac conduction defects, and sudden death but also DCM, hitherto associated with loss-of-function mutations, for the first time.
Introduction
Mutations in SCN5A encoding the a-subunit of the human cardiac sodium channel have been associated with an increasingly wide range of cardiac rhythm disorders that include not only the long QT syndrome type 3 (LQT3) but also the Brugada syndrome (BrS), cardiac conduction diseases, idiopathic ventricular fibrillation, sinus node dysfunction including sick sinus syndrome (SSS), atrial standstill, dilated cardiomyopathy (DCM), and sudden infant death syndrome, each characterized by distinct electrocardiographic (ECG) and clinical features. [1] [2] [3] [4] [5] [6] Single, specific, SCN5A mutations can thus each result in either single or multiple phenotypes.
Mutations in SCN5A leading to LQT3 are in general associated with a gain-of-channel function with increased late sodium current leading to a delayed repolarization and prolonged action potentials. The first and the most extensively studied mutation in LQT3 has been the deletion of three amino acids KPQ at positions 1505-1507 in the cardiac sodium channel. 7, 8 Similarly, deletions of the three amino acid residues delQKP at position1507-1509 sharing the deletion of Q1507 with the delKPQ exclusively resulted in the same LQT3 phenotype. 9 These mutations located in the DIII-DIV linker region of the cardiac sodium channel involve the inactivation process of the channel. 10 The present study has identified a delQKP mutation at position 1507-1509 of the cardiac sodium channel through three generations of a Chinese family associated with an expanded spectrum of disorders: LQT3, cardiac conduction defects, DCM, and high incidence of youth sudden death. It also excluded possible mutations that would lead to amino acid changes in KCNQ1, HERG, and LAMIN A/C commonly associated with LQT1, LQT2, and DCM with conduction disorders on earlier occasions. [11] [12] [13] The data thus compliments and expands the spectrum of phenotypes resulting from this known mutation, and associates the DCM phenotype with gain, and not only loss of sodium channel function for the first time.
Methods

Clinical investigation
All investigations conformed to principles defined in the Helsinki Declaration. Eleven members of a three-generation Chinese family were investigated (Figure 1) , informed written consent having been obtained from each member. They included a complete medical history, physical examination, at least two 12-lead ECG recordings obtained at different times and echocardiographic scanning. Heart rates, widths of P wave, PR intervals, QRS durations, and QT intervals corrected for heart rate using Bazett's formula (QTc) were measured in limb lead II. QTc intervals were averaged from five consecutive beats of at least two 12-lead ECG recordings at different time points. Resting echocardiography was performed by experts. Global function was digitized using an IE33 system (Philips Medical Systems, Eindhoven, The Netherlands) with 1-5 MHz broadband phased-array transducer connected. Biplane end-diastolic and end-systolic volumes were calculated from the planimetered areas by computer software according to a modified Simpson's rule. Two hundred unrelated control individuals were randomly selected from a group of Chinese healthy volunteers with normal 12-lead ECGs and without reported cardiovascular history.
SCN5A mutation analysis
Genomic DNA was extracted from 10 mL of whole blood using the Puregene Isolation kit (Gentra Systems, USA). The coding regions of SCN5A, KCNQ1, HERG, and LAMIN A/C and their exon-intron boundaries were amplified from genomic DNA by polymerase chain reaction (PCR) using a comprehensive set of primers and PCR conditions as described previously. 7, 13, 14 Bidirectional sequencing was performed by an ABI automated cycle sequencer using an ABI BigDye Terminator Cycle Sequencing Kit (Applied Biosystems, USA). Sequencing results were aligned with the respective wild-type sequences to detect genetic variations. The identified mutation was screened among the remaining family members by direct DNA sequencing. The mutations were further verified by single strand conformational polymorphism analysis (SSCP). The same mutation was also screened among 200 controls with the same ethnic background.
Results
Clinical features in the proband
The proband ( Figure 1 , subject III-2) is a 13-year-old girl, who was diagnosed with a cardiac conduction disorder identified as second-degree (Mobitz type II) atrioventricular (AV) block, prolonged QTc, and AV junctional ectopic beats, by a 12-lead ECG at 40 days after birth with heart rates ranging from 60 to 120 bpm. Further assessment at 2 months had revealed a bradycardic heart rate of 75 bpm, QTc prolongation, left axis deviation, and left anterior fascicular block (LAFB). At 4 months, she showed an atrial rate of 125 bpm and a third-degree AV block with a ventricular rate of 60 bpm. At the end of 2 years of life, the ECG conduction abnormalities consisted of a 2:1 second-degree AV block with intermittent episodes of third-degree AV block in successive ECG recordings, but an absence of significant atrial or ventricular arrhythmias. However, she did not present again with symptoms until 8 years of age, when she presented with a history of multiple episodes of syncope and seizure triggered by fits of anger that persisted over the subsequent 5 years, despite being normal to electroencephalographic examination. The episodes occurred reproducibly and were short-lived and followed by prompt and complete recovery. She also had recurrent nocturnal dyspnoeic episodes over this period.
At the end of this period, she was a paediatric cardiological patient, presenting with multiple episodes of syncope and seizure. Within hours following admission, continuous ECG monitoring during such multiple episodes led to a diagnosis of ventricular fibrillation and torsade de pointe (TdP) that was reversed by electrode defibrillation. Subsequent 12-lead ECG recording revealed a sinus rate with a relative risk interval of 680 ms, which on some follow-up measurements increased to as much as 1132 ms. In addition, there was a borderline PR interval (200 ms) and normal QRS durations (100 ms), features of intraventricular conduction delay consisting of LAFB and incomplete right bundle-branch block (IRBBB). QTc interval was prolonged (750 ms) and T-waves were biphasic with a delayed onset (Figure 2A ). Continuous ECG monitoring revealed self-terminating episodes of TdP (Fig. 2B) . Transthoracic echocardiography revealed a LV dilatation with end-diastolic and end-systolic volumes (LVEDV and LVESV) of 156 mL and 98 mL, respectively, low ejection fraction (EF) of 37% ( Table 1 ) and a thin ventricular wall ( Figure 2C ). There was a clear reduction of LV myocardial motion on Doppler tissue imaging to 4 mm/s ( Figure 2D ). Immediate treatment involved insertion of a temporary cardiac pacemaker; this was succeeded by b-adrenergic blocker maintenance therapy.
Family pedigree
Subject I-2 had a history of multiple episodes of syncopy at an age ,55 years, but not at ages beyond this. The 12-lead ECGs revealed borderline PR intervals (200 ms) and QRS durations (120 ms), LAFB, prolonged QTc intervals (550 ms) with a significant leftward shift of the electrical axis. Echocardiographic examination demonstrated a LVEDV of 188 mL, a LVESV of 124 mL and an EF of 34% ( Table 1) . Subject II-4, the proband's father had already died suddenly at 33 years of age during a Valsalva manoeuvre despite having no history of syncope. Subject II-1, one of the proband's aunts had died suddenly at age 13 years after an angry argument. Subjects II-1, II-3, II-5, II-6, III-1, and III-3 appeared normal with no history of syncope, sudden death, or cardiovascular events. The 12-lead ECG's revealed normal QTc intervals and transthoracal echocardiography revealed normal cardiac structure and function. None of the subjects fulfilled criteria for arrhythmogenic right ventricular dysplasia. Table 1 shows a summary of ECG, echocardiography parameters, and clinical information about the live members of the family pedigree.
Genetic analysis
A heterozygous deletion of nine base pairs (CAGAAGCCC) in exon 26 of SCN5A ( Figure 3A) , corresponding to the three amino acid residues Gln1507-Lys1508-Pro1509 (QKP) was found ( Figure 3B ) in the proband (subject III-2) and his grandmother (subject I-2) and excluded in the remaining living subjects in this family. This mutation was confirmed using SSCP ( Figure 3C) . The inframe-deletion disrupts the coding sequence of QKP at the terminal part of exon 26 and is localized in the linker region between DIII and DIV of the Nav1.5 sodium channel ( Figure 3D) . Similar analysis excluded possible mutations that would lead to amino acid changes in KCNQ1, HERG, and LAMIN A/C commonly associated with LQT1, LQT2, and DCM with conduction disorders on earlier occasions: [11] [12] [13] we did not find new mutations that would lead to amino acid changes. Three base substitutions were observed in HERG: 1480C!T, 1552C!T, and 1705A!G, but these would not have altered the encoded amino acid.
Discussion
This paper associates multiple clinical cardiac phenotypes with the gain-of-function, delQKP1507-1509 sodium channel mutation, in the linker region between DIII and DIV, associated with channel inactivation, for the first time. This adds to previous reports and identifications of this mutation through three generations of a family pedigree that had then observed only a single, LQT3, phenotype. 9 Previous biophysical studies of this delQKP1507-1509 mutation had revealed persistent residual sodium currents that were 1-1.5% of the maximum current magnitude measured at 230 mV nearly completely blocked by the sodium-channel blockers, tetrodotoxin and lidocaine. These findings were additionally associated with significant positive shifts of steady-state activation 9 and negative shifts in inactivation. 9 Such features correlated with a LQT phenotype, consistent with previous studies of other SCN5A mutations causing LQTS. 7, [15] [16] [17] However, persistent inward currents associated with LQT-related mutations have also been reported to result in bradycardia and sinus pauses resulting from sinoatrial node cells failing to repolarize under conditions of extra net inward current suggesting the possibility of additional phenotypic characteristics. 18 The present clinical report fulfills such biophysical predictions.
These findings also complement other reports that single sodium channel mutations can result in multiple phenotypes giving rise to an 'overlap syndrome' as well as unique isolated phenotypes in which a mutation expected to result in a gain-of-function results in phenotypes that include changes suggestive instead of a loss-of-function. [19] [20] [21] [22] Thus, the C-terminal SCN5A mutation (1795insD) is associated with 68  58  200  100  400  122  50  59  I-2  F  65  88  200  120, LAFB  550  188  124  34  II-2  F  44  71  160  80  430  101  38  62  II-4  F  40  65  120  90  430  106  41  61  II-6  F  35  70  140  90  430  88  32  64  III-1  M  18  75  160  100  440  92  34  64  III-2  F  13  92  120  100; LAFB; IRBBB  750  156  98  37  III-3  F  11  73  140  90  430  136  54  60 LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LAFB, left anterior fascicular block; IRBBB, incomplete right bundle-branch block; EF, ejection fraction. Simpson's method was used to record the data. several clinical ECG features of bradycardia, conduction disease, LQT3, and BrS. 23, 24 There is a similar bradycardia, right ventricular conduction slowing, and QT prolongation in the corresponding Scn5a1798insD/þ murine model, 25 which shows 39% reductions in peak sodium current density resulting in a similar reduction in action potential upstroke velocity accounting for conduction disorder; delays in fast inactivation, and persistent sodium currents resulting in action potential prolongation. The persistent inward current may also account for the observed bradycardia and sinus pauses resulting from sinoatrial node cells failing to repolarize under conditions of extra net inward current. 18 Similarly, patients carrying a deletion of a lysine in the intracellular DIII-DIV linker (delK1500), located close to the LQT3-associated mutation delKPQ1505-1507, have also been shown to display a heterogeneous clinical phenotype with symptoms of long-QT syndrome, BrS, and conduction disease. 21 However, there have been relatively few clinical reports associating Na þ channel abnormalities with DCM, most strikingly observed in 13-year-old proband, and all of these have consistently resulted in loss-rather than gain-of-function. 26 Olson et al. localized a form of congenital DCM (CMD1E) characterized by progression toward atrial dilatation, frequently followed by right and, sometimes left ventricular dilatation and dysfunction 27 to a heterozygous mutation (3823 G!A) in exon 21 leading to a D1275N substitution in the S3 transmembrane region of domain III of SCN5A. 6 This had previously been mapped to chromosome 3p22-p25. 28 It resulted in a þ3.8 mV shift in sodium conductance activation curves in a Xenopus oocyte expression system. 4 A more extensive analysis then identified 156 unrelated DCMpatients negative for mutations in other associated genes including those encoding cardiac actin, a-tropomyosin, and metavinculin. However, they showed alterations in four highly conserved residues in the transmembrane domains of SCN5A. Such patients also showed a range of phenotypes including SSS, atrial and ventricular arrhythmias, and congenital conduction disease. In contrast, the present findings associated DCM with a gain-of-function, delQKP1507-1509, mutation for the first time.
In summary, the present study identified a gain-offunction, delQKP, mutation at position 1507-1509 of the cardiac sodium channel in a three generation Chinese family associated with an expanded spectrum of disorder: LQT3, cardiac conduction defects, DCM and high incidence of youth sudden death. These data compliment previous reports of an expanding spectrum of phenotypes of this known mutation, as well as associating the DCM phenotype with gain-of-function sodium channel mutations for the first time.
